Occam Crest Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,000
Closed -$658K 32
2025
Q3
$658K Buy
+2,000
New +$5.65K 0.4% 29

Other funds holding PGEN

Occam Crest Management's PGEN Position: Q1 2026 in Review

Occam Crest Management increased its Precigen (PGEN) stake by 22% in Q1 2026, buying an estimated $3.15M and bringing the position to 4,269,051 shares worth $16.5M. The position accounts for 10.03% of the portfolio, ranked #2.

Occam Crest Management first reported a position in PGEN in Q3 2025 and has held it in 3 quarters since. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Occam Crest Management held 4,269,051 shares of Precigen worth $16.5M as of Q1 2026.
  • Occam Crest Management bought 767,312 Precigen shares in Q1 2026, an estimated $3.15M.
  • Precigen made up 10.03% of Occam Crest Management's portfolio in Q1 2026, its #2 holding.
  • Occam Crest Management first reported a position in Precigen in Q3 2025 and has held it in 3 quarters since.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Occam Crest Management's 13F filing for Q1 2026, filed 15 May 2026.